HUM vs CVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

HUM

53.8
AI Score
VS
HUM Wins

CVS

50.7
AI Score

Investment Advisor Scores

HUM

54score
Recommendation
HOLD

CVS

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HUM CVS Winner
Forward P/E 40.1606 14.3678 CVS
PEG Ratio 2.0698 0.2982 CVS
Revenue Growth 26.2% 6.1% HUM
Earnings Growth 27.1% 63.1% CVS
Tradestie Score 53.8/100 50.7/100 HUM
Profit Margin 0.9% 0.7% HUM
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HUM 1M: -7.1% · 3M: +57.8% CVS 1M: +0.5% · 3M: +28.2%

Current Technical Phase

HUM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.1 · Price: $368.66

CVS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.9% over 20 days), RSI 52

RSI (14): 51.6 · Price: $105.21

Fundamentals Snapshot

Metric HUM CVS
Market Cap
Forward P/E 22.4 12.4
Trailing P/E 34.5 46.6
Revenue (TTM)
Revenue Growth 0.3% 0.1%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.0%
EPS 10.63 2.26
Dividend Yield 0.00% 0.03%

Frequently Asked Questions

Based on our detailed analysis, HUM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.